Adjuvant antibiotic-loaded bone cement: Concerns with current use and research to make it work
JournalJournal of Orthopaedic Research
PublisherJohn Wiley and Sons Inc.
MetadataShow full item record
AbstractAntibiotic-loaded bone cement (ALBC) is broadly used to treat orthopaedic infections based on the rationale that high-dose local delivery is essential to eradicate biofilm-associated bacteria. However, ALBC formulations are empirically based on drug susceptibility from routine laboratory testing, which is known to have limited clinical relevance for biofilms. There are also dosing concerns with nonstandardized, surgeon-directed, hand-mixed formulations, which have unknown release kinetics. On the basis of our knowledge of in vivo biofilms, pathogen virulence, safety issues with nonstandardized ALBC formulations, and questions about the cost-effectiveness of ALBC, there is a need to evaluate the evidence for this clinical practice. To this end, thought leaders in the field of musculoskeletal infection (MSKI) met on 1 August 2019 to review and debate published and anecdotal information, which highlighted four major concerns about current ALBC use: (a) substantial lack of level 1 evidence to demonstrate efficacy; (b) ALBC formulations become subtherapeutic following early release, which risks induction of antibiotic resistance, and exacerbated infection from microbial colonization of the carrier; (c) the absence of standardized formulation protocols, and Food and Drug Administration-approved high-dose ALBC products to use following resection in MSKI treatment; and (d) absence of a validated assay to determine the minimum biofilm eradication concentration to predict ALBC efficacy against patient specific micro-organisms. Here, we describe these concerns in detail, and propose areas in need of research.
Keywordantibiotic-loaded bone cement (ALBC)
musculoskeletal infection (MSKI)
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85081232301&doi=10.1002%2fjor.24616&partnerID=40&md5=53fc792a32faa8110e385287723ad712; http://hdl.handle.net/10713/12327
- Use of antibiotic-loaded cement in total knee arthroplasty.
- Authors: Hinarejos P, Guirro P, Puig-Verdie L, Torres-Claramunt R, Leal-Blanquet J, Sanchez-Soler J, Monllau JC
- Issue date: 2015 Dec 18
- The cost-effectiveness of antibiotic-loaded bone cement versus plain bone cement following total and partial knee and hip arthroplasty.
- Authors: Hoskins T, Shah JK, Patel J, Mazzei C, Goyette D, Poletick E, Colella T 2nd, Wittig J
- Issue date: 2020 Jul-Aug
- An Approach for determining antibiotic loading for a physician-directed antibiotic-loaded PMMA bone cement formulation.
- Authors: Lewis G, Brooks JL, Courtney HS, Li Y, Haggard WO
- Issue date: 2010 Aug
- The Hidden Cost of Commercial Antibiotic-Loaded Bone Cement: A Systematic Review of Clinical Results and Cost Implications Following Total Knee Arthroplasty.
- Authors: King JD, Hamilton DH, Jacobs CA, Duncan ST
- Issue date: 2018 Dec
- Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity.
- Authors: McLaren AC, Nugent M, Economopoulos K, Kaul H, Vernon BL, McLemore R
- Issue date: 2009 Jul